Prognostic value of vascular remodeling parameters in the development of adverse cardiovascular events in patients with gastric cancer

QR Code

Prognostic value of vascular remodeling parameters in the development of adverse cardiovascular events in patients with gastric cancer

Aim. To determine a possible prognostic marker for adverse cardiovascular events in patients with gastric cancer by studying the early and long-term effects of multiagent chemotherapy (MAC) on the structural and functional vascular wall parameters.Material and methods. The study included 25 patients...

Full description

Saved in:

Bibliographic Details
Main Authors:	Y. Yu. Kirichenko, I. S. Ilgisonis, P. A. Levin, Y. N. Belenkov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2022-12-01
Series:	Российский кардиологический журнал
Subjects:	gastric cancer cardiotoxicity vascular toxicity multiagent chemotherapy cardiovascular remodeling endothelial dysfunction
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5230
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cardiovascular toxicity of antitumor therapy: effect on myocardial and vascular remodeling
by: Yu. Yu. Kirichenko, et al.
Published: (2021-11-01)

Vascular Remodeling Markers in Patients with Essential Arterial Hypertension Depending on Presence of Type 2 Diabetes Mellitus
by: Yu. A. Danilogorskaya, et al.
Published: (2019-07-01)

Circumferentially Aligned Electrospun Vascular Grafts Improves Its Vascular Regeneration and Remodeling in vivo
by: Xiong M, et al.
Published: (2025-06-01)

THE ROLE OF VASCULAR REMODELING IN THE FORMATION OF STRUCTURAL PHENOTYPES OF OSTEOARTHRITIS
by: M. A. KABALYK, et al.
Published: (2018-07-01)

ARTERIAL HYPERTENSION DURING THERAPY OF ONCOLOGICAL DISEASES WITH ANGIOGENESIS INHIBITORS: SERIOUS IMPEDIMENT OR CONTROLLED REACTION?
by: Zh. D. Kobalava, et al.
Published: (2017-06-01)

INFLUENCE OF THE COMBINATION DRUG PRESTANS (PERINDOPRIL A, AMLODIPINE) ON MORPHO-FUNCTIONAL PARAMETERS OF ARTERIAL BED IN ESSENTIAL HYPERTENSION
by: Yu. A. Danilogorskaya, et al.
Published: (2017-12-01)

BIOMECHANICAL REMODELING OF BIODEGRADABLE SMALL-DIAMETER VASCULAR GRAFTS IN SITU
by: T. V. Glushkova, et al.
Published: (2016-06-01)

CHEMOTHERAPY CARDIOTOXICITY SCREENING WITH CARDIAC TROPONINS
by: O. V. Krikunova, et al.
Published: (2015-12-01)

vASCULAR AND CARDIAC REMODELLING AND COMbINATION THERAPY OF ARTERIAL HYPERTENSION IN PATIENTS WITH CHRONIC ObSTRUCTIvE PULMONARY DISEASE
by: L. A. Shpagina, et al.
Published: (2014-01-01)

THE CHRONIC PSYCHO-EMOTIONAL STRESS IS ACCOMPANIED BY ENDOTHELIAL DYSFUNCTION, PROMOTES VASCULAR REMODELING AND REDUCTION OF CEREBRAL PERFUSION
by: I. S. Lutskiy
Published: (2015-06-01)

VASCULAR REMODELING AND HEART RATE VARIABILITY IN DIFFERENT ANTIHYPERTENSIVE THERAPIES
by: E. D. Golovanova
Published: (2016-01-01)

Arterial remodeling in older patients with arterial hypertension
by: A. V. Agafonov, et al.
Published: (2005-06-01)

Knowledge-based Algorithms for BDI-agents
by: Nikolay Vyacheslavovich Shilov, et al.
Published: (2020-12-01)

Early vascular remodeling role in arterial hypertension pathogenesis among young patients
by: I. V. Milyagina, et al.
Published: (2006-08-01)

Endothelial Features Along the Pulmonary Vascular Tree in Chronic Thromboembolic Pulmonary Hypertension: Distinctive or Shared Facets?
by: Janne Verhaegen, et al.
Published: (2025-04-01)

The cardiovascular system in patients with anthracycline cardiomiopathy
by: Alexandr T. Teplyakov, et al.
Published: (2017-10-01)

HDL attenuates Ang II–AT1R–EGFR signaling and reverses vascular remodeling in spontaneously hypertensive rats
by: Aishah Al-Jarallah, et al.
Published: (2025-07-01)

Сonsensus statement of Russian experts on the prevention, diagnosis and treatment of cardiotoxicity of anticancer therapy
by: Yu. A. Vasyuk, et al.
Published: (2021-10-01)

Vascular markers of cognitive dysfunction in patients with uncontrolled arterial hypertension
by: V. I. Podzolkov, et al.
Published: (2020-11-01)

ANALYSIS OF THE RELATIONSHIP BETWEEN RENAL REMODELING AND VASCULAR ADHESION-1 PROTEIN (VAP-1) IN CHRONIC PRIMARY GLOMERULONEPHRITIS
by: H. Z. Gadaborsheva, et al.
Published: (2017-08-01)

Lipid profile changes in patients with acute leukemia after pathogenetic therapy
by: E. A. Praskurnichy, et al.
Published: (2025-05-01)

The importance of angiogenesis and lymphangiogenesis in gastric cancer
by: I. V. Maiborodin, et al.
Published: (2025-07-01)

Correction: Endothelial AIP1 regulates vascular remodeling by suppressing NADPH Oxidase-2
by: Jiqin Zhang, et al.
Published: (2025-08-01)

Longitudinal Assessment of QT Apex in Tumor‐Bearing Dogs Receiving Doxorubicin Monotherapy
by: Keita Kitagawa, et al.
Published: (2025-07-01)

Assessment of the safety and feasibility of neoadjuvant chemotherapy (2 cycles of FLOT chemotherapy + chemoradiotherapy) followed by surgery in the treatment of locally advanced gastric cancer
by: D. Yu. Mironova, et al.
Published: (2024-03-01)

Relation of the heart remodeling and endothelial dysfunction in chronic heart failure patients
by: Ch. A. Abdullaeva, et al.
Published: (2016-02-01)

Arterial stiffness and 24-hour blood pressure profile in women with breast cancer before and after chemotherapy with doxorubicin and cyclophosphamide
by: T. S. Satalkina, et al.
Published: (2025-03-01)

Change of concentration of biochemical markers of dysfunction of endothelium at intake of inhibitors of tyrosinekinase of I and II generations at patients with a chronic myeloid leukemia as risk factor of development of cardiovascular complications
by: K. V. Naumova, et al.
Published: (2021-01-01)

Cardiovascular remodeling and calcium-regulating function of parathyroid glands in arterial hypertension
by: B. G. Iskenderov, et al.
Published: (2007-04-01)

Analysis of Cardiotoxicity and Risk Factors of Breast Cancer Chemotherapy Drugs: A Five-Year Single-Centre Retrospective Study in Early Breast Cancer
by: Ju F, et al.
Published: (2025-07-01)

OUR EXPERIENCE OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PATIENTS WITH ADVANCED GASTRIC CANCER
by: A. D. Kaprin, et al.
Published: (2016-01-01)

Short-term efficacy and toxicity of total neoadjuvant chemotherapy in patients with resectable gastric cancer
by: A. V. Avgustinovich, et al.
Published: (2022-03-01)

Neoadjuvant systemic therapy for patients with gastric cancer: Current concepts and outcomes
by: Fatih Selcukbiricik, et al.
Published: (2016-01-01)

Evolution of drug therapy in patients with resectable gastric and esophageal‑gastric junction cancer
by: M. V. Sedova, et al.
Published: (2023-06-01)

Atrial fibrillation in a patient with lung cancer: a case report
by: E. Yu. Shupenina, et al.
Published: (2022-12-01)

Influence of trimetazidine on myocardium energy balance during chemotherapy with doxorubicin and cyclophosphamide
by: A. A. Avagimyan
Published: (2022-06-01)

Advancing The Cardiovascular Care in Cancer Patients on Chemotherapy
by: Muhammad Yamin, et al.
Published: (2024-01-01)

Treatment patterns, outcomes and long-term toxicity among patients with Hodgkin’s lymphoma in real world: results of a hospital based registry
by: E. A. Nikitin, et al.
Published: (2016-10-01)

Vascular ageing: main symptoms and mechanisms
by: I. D. Strazhesko, et al.
Published: (2012-08-01)

The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy
by: A. T. Teplyakov, et al.
Published: (2019-03-01)